FDA NDC Directory · JSON-LD · Markdown

Darzalex IV

NDC 57894-505 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameDaratumumab
Labeler / ManufacturerJanssen Biotech, Inc.
Marketing categoryBiologic License Application · App BLA761036
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsDARATUMUMAB (100 mg/5mL)
Marketing started20211015
Package count2

External sources

Source: openFDA. Public-domain (CC0).